Results 101 to 110 of about 39,714 (159)

Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis. [PDF]

Allergy Asthma Proc
Davis-Lorton M, Soteres D, Lumry WR, Hall J, Connolly H, Fox D, Sing K, Schultz BG, Juethner S.   +8 more
europepmc   +1 more source

Therapeutic Targets for Lung Squamous Cell Carcinoma: Proteome‐Wide Mendelian Randomization and Potential Drug Prediction

The Clinical Respiratory Journal, Volume 20, Issue 3, March 2026.
This flowchart shows the main contents of our study, including main analysis, sensitivity analysis, and survival analysis. The figure briefly shows the source of our data, as well as some other screening requirements. The main finding of mendelian randomization was that three of the plasma proteins were shown to be associated with the risk of LUSC ...
Tao Xiang, Tingting Hu, Jiantong Sun, Qikun Geng, Jiazun Yang, Zhongyu Jian   +5 more
wiley   +1 more source

Dermatomyositis masquerading as angioedema: a crucial differential not to overlook. [PDF]

BMJ Case Rep
Chan K, Kwan G, Soh HC, Evans L.
europepmc   +1 more source

Simulating the impact of an educational and digital approach using patient journey modelling to overcome practical challenges in the management of chronic spontaneous urticaria in Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-346, March 2026.
Summary Background and Objective Despite the availability of guidelines and effective escalation therapies, chronic spontaneous urticaria (CSU) is often inadequately treated in Germany. Implementation science can help to transfer evidence‐based care into practice.
Ralph von Kiedrowski, Mark Berneburg, Mona Biermann, Hanna Bonnekoh, Michael Fritz, Max Tischler, Martin Metz, Sebastian Volc, Nicola Wagner, Alexander Zink, Petra Nathan   +10 more
wiley   +1 more source

Burden of disease in adult patients with hereditary angioedema: results from a multinational survey. [PDF]

Orphanet J Rare Dis
Watt M, Martinez-Saguer I, Simon A, Murphy R, Cruz M, Zwiener R, Sarrazola M, Grumach AS.   +7 more
europepmc   +1 more source

Simulation der Auswirkungen eines edukativen und digitalen Ansatzes unter Verwendung von Patient‐Journey‐Modellen, um praktische Herausforderungen bei der Behandlung der chronischen spontanen Urtikaria in Deutschland zu bewältigen

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 338-348, March 2026.
Zusammenfassung Hintergrund und Zielsetzung Trotz verfügbarer Leitlinien und effektiver Eskalationstherapien wird die chronisch spontane Urtikaria (CSU) in Deutschland häufig unzureichend behandelt. Implementation Science kann helfen, evidenzbasierte Versorgung in die Praxis zu überführen.
Ralph von Kiedrowski, Mark Berneburg, Mona Biermann, Hanna Bonnekoh, Michael Fritz, Max Tischler, Martin Metz, Sebastian Volc, Nicola Wagner, Alexander Zink, Petra Nathan   +10 more
wiley   +1 more source

Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolution. [PDF]

World Allergy Organ J
Mak HWF, Longhurst HJ, Magerl M, Peter J, Riedl M, Li PH.   +5 more
europepmc   +1 more source

Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1956-1971, March 2026.
Abstract Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for type 2 diabetes mellitus and obesity, with once‐weekly dosing that supports adherence. However, injection‐site reactions (ISRs) and dermatologic events have been recognised, ranging from mild local events to rare systemic hypersensitivity reactions that may cause ...
Shifa Taj, Mohammed Zuber, Muhammed Rashid, Manik Chhabra, Krishna Undela, Smita Rawal, Lorenzo Villa Zapata   +6 more
wiley   +1 more source

Assessing Patient-Reported Outcomes in Acute Attacks of Hereditary Angioedema: Insights from a Mixed Methods Study of Participants Receiving Standard-of-Care Treatments in a Real-World Setting. [PDF]

Clin Rev Allergy Immunol
Mendivil J, Zhu L, Bonner N, Gargon E, Jouvin MH, Abetz-Webb L, Fairbanks H, Sims J, Middlehurst J, Cronin P, Chen M, Cohn DM, Lu P, Riedl MA.   +13 more
europepmc   +1 more source

Effects of Aliskiren Monotherapy on Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Blood Pressure and Urinary Protein Excretion Outcomes

The Journal of Clinical Hypertension, Volume 28, Issue 3, March 2026.
ABSTRACT Aliskiren has been proposed as an alternative for renin‐angiotensin system blockage in chronic kidney disease (CKD); however, its efficacy and safety remain uncertain. The objective of this study was to evaluate the antihypertensive and antiproteinuric effects of aliskiren monotherapy in patients with CKD and hypertension.
N M Mahmudul Alam Bhuiya, Joshua Caballero, Henry N. Young, Lorenzo Villa‐Zapata   +3 more
wiley   +1 more source